Report Categories
View AllRecent Articles
View All
The key risks discussed in Devon Energy DVN earnings Q4 2025 Profit Exceeds Views
What sustainable investing NewAmsterdam NAMSW 561 20260429
First Trust Natural Gas ETF FCG Positioned to Capture Structural European LNG Demand Amid Geopolitical Volatility
Pfizer Inc PFE Secures Temporary Generic Exclusivity Extension for Blockbuster Heart Drug Vyndamax Through 2031
Microsoft Flags 190B Capital Spending Need by 2026 Amid Memory Price Surge
DSP Mutual Fund Flags Indian Rupee as Undervalued Amid Macroeconomic Strength
Burberry Shares Surge on Reports of Potential Moncler Acquisition Bid
Wingstop Shares Drop 12 After Earnings Miss Profit Expectations
Ledn Projects 1 Trillion Potential in BitcoinBacked Lending Market
AnheuserBusch InBev Shares Decline on Sales Miss
IBTA Q1 2026 Earnings EPS Misses Estimates Stock Edges Higher
EA Q1 2026 Earnings EPS Misses Estimates Stock Declines
WHLRL Q2 2024 Earnings Bondholder EPS Surprises Revenue Unreported
MLP Q1 2024 Earnings Net Loss Per Share Improves as Company Advances Strategic Land Initiatives
NanoViricides Inc NNVC Q1 2026 Earnings Narrower Loss Drives Positive Stock Reaction
HUBG Q3 2025 Earnings Modest EPS Miss Amid Positive Market Sentiment
Mercantile Bank Corporation MBWM Edges Lower as Shares Test Key Support Levels
Trailblazer Acquisition Corp Unit BLZRU Holds Steady Near 1021 as Trading Activity Remains Subdued
Jupiter Neurosciences JUNS Gains 10 as Trading Volume Picks Up Near Key Resistance
Paylocity PCTY Holds Steady Near Resistance Consolidation or Breakout
KalVista Pharmaceuticals KALV Holds Steady Near Support as Biotech Sector Watches for Catalyst
External Links
Federal Judge Accused of Sexual Misconduct in Chambers With Police Officer Disciplinary Panel Reveals
One Liberty Properties Inc OLP Q1 2026 Earnings EPS Beats Estimates on Solid Property Performance
Clear Channel Outdoor Holdings CCO Slips Fractionally as Traders Eye Key Support Levels
Kairos Pharma Ltd KAPA Q1 2026 Earnings EPS Misses Estimates as Stock Declines 411
OCCI Q1 2026 Earnings Significant EPS Miss Driven by Losses in Credit Portfolio
Accenture Q1 2026 Earnings EPS Surpasses Estimates Despite Stock Dip
ESLA Q1 2026 Earnings EPS Misses Estimates by Wide Margin as ClinicalStage Biotech Continues RD Spending
BIP Q1 2026 Earnings Significant EPS Miss Amidst Operational Headwinds
CALM Q1 2026 Earnings Earnings Per Share Surges 299 Above Estimates Stock Reacts Mildly
ACIW Q1 2026 Earnings EPS Beats Estimates by 1267 Stock Rises Slightly